No Result
View All Result
SUBMIT YOUR ARTICLES
  • Login
Saturday, June 6, 2026
TheAdviserMagazine.com
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
No Result
View All Result
TheAdviserMagazine.com
No Result
View All Result
Home Market Research Markets

CAG Earnings: Key quarterly highlights from Conagra Brands’ Q1 2026 financial results

by TheAdviserMagazine
8 months ago
in Markets
Reading Time: 1 min read
A A
CAG Earnings: Key quarterly highlights from Conagra Brands’ Q1 2026 financial results
Share on FacebookShare on TwitterShare on LInkedIn


Conagra Brands, Inc. (NYSE: CAG) reported its first quarter 2026 earnings results today.

Net sales decreased 5.8% year-over-year to $2.63 billion. Organic net sales decreased 0.6%.

CAG Earnings: Key quarterly highlights from Conagra Brands’ Q1 2026 financial results

Net income attributable to Conagra Brands decreased 64.8% to $165 million, or $0.34 per share, compared to last year. Adjusted EPS was $0.39, down 26.4% from last year.

The results beat expectations, sending the stock up over 1% in premarket hours on Wednesday.

In Q1, net sales in the Grocery & Snacks segment decreased 8.7% to $1.1 billion. Net sales for the Refrigerated & Frozen segment decreased 0.9% to $1.1 billion. Net sales in the International segment declined 18% to $212 million while net sales for the Foodservice segment dipped 0.8% to $264 million.

For fiscal year 2026, the company expects organic sales growth to be down 1% to up 1% compared to fiscal year 2025. Adjusted EPS is expected to be $1.70-1.85.

The post CAG Earnings: Key quarterly highlights from Conagra Brands’ Q1 2026 financial results first appeared on AlphaStreet.



Source link

Tags: BrandsCAGConagraearningsfinancialHighlightskeyQuarterlyresults
ShareTweetShare
Previous Post

MODEC secures full EPCI contract to deliver FPSO for Hammerhead project

Next Post

SIPs for first-timers, lumpsums for veterans in JioBlackRock Flexi Cap Fund: Rishi Kohli

Related Posts

edit post
Separate Checks? 7 Money Tips for Older Daters

Separate Checks? 7 Money Tips for Older Daters

by TheAdviserMagazine
June 6, 2026
0

Life’s too short to let money issues spoil a first date – especially in the autumn of your life. For...

edit post
Trump Explores Federal Government Acquiring Shares in AI Companies

Trump Explores Federal Government Acquiring Shares in AI Companies

by TheAdviserMagazine
June 5, 2026
0

WASHINGTON — President Donald Trump said he’s exploring having the federal government acquire shares in artificial intelligence companies, likening the...

edit post
Cboe (CBOE) Has a Data-and-Clearing Engine That Looks Better Than a Volatility Trade

Cboe (CBOE) Has a Data-and-Clearing Engine That Looks Better Than a Volatility Trade

by TheAdviserMagazine
June 5, 2026
0

Cboe (CBOE) is easy to misread because its business sits so close to market activity. When volumes spike, the stock...

edit post
Hot jobs report puts Fed cuts further out of reach as Chair Warsh faces policy tests

Hot jobs report puts Fed cuts further out of reach as Chair Warsh faces policy tests

by TheAdviserMagazine
June 5, 2026
0

New Chairman of the Federal Reserve Kevin Warsh arrives during a swearing in ceremony in the East Room of the...

edit post
Crypto mutiny on Strategy: Shorts target ‘MSTR’ in bitcoin bloodbath

Crypto mutiny on Strategy: Shorts target ‘MSTR’ in bitcoin bloodbath

by TheAdviserMagazine
June 5, 2026
0

Options traders are storming into bets against crypto's most vocal evangelist Michael Saylor. Call it mutiny on Strategy.Flows around Saylor's...

edit post
TransDigm (TDG) Still Has an Aftermarket-and-Pricing Engine That Looks Stronger Than the Leverage Debate

TransDigm (TDG) Still Has an Aftermarket-and-Pricing Engine That Looks Stronger Than the Leverage Debate

by TheAdviserMagazine
June 5, 2026
0

TransDigm (TDG) is often framed as a leveraged aerospace supplier whose upside depends mainly on air-travel demand. That view misses...

Next Post
edit post
SIPs for first-timers, lumpsums for veterans in JioBlackRock Flexi Cap Fund: Rishi Kohli

SIPs for first-timers, lumpsums for veterans in JioBlackRock Flexi Cap Fund: Rishi Kohli

edit post
How AI and Data Speed Up and Scale B2B Resale

How AI and Data Speed Up and Scale B2B Resale

  • Trending
  • Comments
  • Latest
edit post
Supreme Court Delivers More Bad Redistricting News for Democrats

Supreme Court Delivers More Bad Redistricting News for Democrats

May 19, 2026
edit post
From Maine to Michigan, Democrats Are Making Communism Great Again

From Maine to Michigan, Democrats Are Making Communism Great Again

May 16, 2026
edit post
It’s Time To Talk About Massie

It’s Time To Talk About Massie

May 23, 2026
edit post
Red Snapper Used as Cudgel by Fed Judge

Red Snapper Used as Cudgel by Fed Judge

May 31, 2026
edit post
10 Cheapest High Dividend Stocks With P/E Ratios Under 10

10 Cheapest High Dividend Stocks With P/E Ratios Under 10

April 13, 2026
edit post
Health insurers are exiting the Marketplace again. Should consumers be worried?

Health insurers are exiting the Marketplace again. Should consumers be worried?

May 27, 2026
edit post
Separate Checks? 7 Money Tips for Older Daters

Separate Checks? 7 Money Tips for Older Daters

0
edit post
Civilizations Are Transaction Costs | Mises Institute

Civilizations Are Transaction Costs | Mises Institute

0
edit post
Want In On SpaceX? Kraken Unveils Early IPO Access Via xStocks

Want In On SpaceX? Kraken Unveils Early IPO Access Via xStocks

0
edit post
5 Reasons Every Woman Needs a Bone-Density Test After 65

5 Reasons Every Woman Needs a Bone-Density Test After 65

0
edit post
Novo’s Wegovy Pill Isn’t Just Beating Expectations — It’s Obliterating Them. Is the Beaten-Down Stock a Buy Now?

Novo’s Wegovy Pill Isn’t Just Beating Expectations — It’s Obliterating Them. Is the Beaten-Down Stock a Buy Now?

0
edit post
What Is Driving Expansion in the Digital Breast Tomosynthesis Market?

What Is Driving Expansion in the Digital Breast Tomosynthesis Market?

0
edit post
Novo’s Wegovy Pill Isn’t Just Beating Expectations — It’s Obliterating Them. Is the Beaten-Down Stock a Buy Now?

Novo’s Wegovy Pill Isn’t Just Beating Expectations — It’s Obliterating Them. Is the Beaten-Down Stock a Buy Now?

June 6, 2026
edit post
Want In On SpaceX? Kraken Unveils Early IPO Access Via xStocks

Want In On SpaceX? Kraken Unveils Early IPO Access Via xStocks

June 6, 2026
edit post
5 Reasons Every Woman Needs a Bone-Density Test After 65

5 Reasons Every Woman Needs a Bone-Density Test After 65

June 6, 2026
edit post
Gen Z is ditching college for ‘more secure’ trade jobs—but these rank among worst entry-level jobs

Gen Z is ditching college for ‘more secure’ trade jobs—but these rank among worst entry-level jobs

June 6, 2026
edit post
Civilizations Are Transaction Costs | Mises Institute

Civilizations Are Transaction Costs | Mises Institute

June 6, 2026
edit post
Michael Hudson: Geopathology and the Econopathology Behind it

Michael Hudson: Geopathology and the Econopathology Behind it

June 6, 2026
The Adviser Magazine

The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.

CATEGORIES

  • 401k Plans
  • Business
  • College
  • Cryptocurrency
  • Economy
  • Estate Plans
  • Financial Planning
  • Investing
  • IRS & Taxes
  • Legal
  • Market Analysis
  • Markets
  • Medicare
  • Money
  • Personal Finance
  • Social Security
  • Startups
  • Stock Market
  • Trading

LATEST UPDATES

  • Novo’s Wegovy Pill Isn’t Just Beating Expectations — It’s Obliterating Them. Is the Beaten-Down Stock a Buy Now?
  • Want In On SpaceX? Kraken Unveils Early IPO Access Via xStocks
  • 5 Reasons Every Woman Needs a Bone-Density Test After 65
  • Our Great Privacy Policy
  • Terms of Use, Legal Notices & Disclosures
  • Contact us
  • About Us

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.